1.59
+0.03(+1.92%)
Currency In USD
| Previous Close | 1.56 |
| Open | 1.6 |
| Day High | 1.6 |
| Day Low | 1.56 |
| 52-Week High | 4.95 |
| 52-Week Low | 1.45 |
| Volume | 24,802 |
| Average Volume | 75,459 |
| Market Cap | 16.94M |
| PE | -4.3 |
| EPS | -0.37 |
| Moving Average 50 Days | 2.03 |
| Moving Average 200 Days | 2.4 |
| Change | 0.03 |
If you invested $1000 in NEXGEL, Inc. (NXGL) since IPO date, it would be worth $451.7 as of December 25, 2025 at a share price of $1.59. Whereas If you bought $1000 worth of NEXGEL, Inc. (NXGL) shares 3 years ago, it would be worth $1,347.46 as of December 25, 2025 at a share price of $1.59.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
NexGelRx Receives Additional Investment from Eric Gruntfest of Diesis Holdings, LLC and Appoints Him as Board Observer and Strategic Advisor
GlobeNewswire Inc.
Dec 16, 2025 1:00 PM GMT
LANGHORNE, Pa., Dec. 16, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products
NEXGEL Announces Spin-Off of Drug Delivery Program into NexGelRx
GlobeNewswire Inc.
Dec 11, 2025 1:00 PM GMT
NEXGEL shareholders will receive a non-dilutive 19.99% equity interest in NexGelRx up to $8 million of capital investment in spin-off NEXGEL will also receive a 5% global royalty in perpetuity on products sold using its drug delivery technology LANGH
NEXGEL to Report Third Quarter 2025 Financial Results on November 11th
GlobeNewswire Inc.
Nov 03, 2025 1:00 PM GMT
Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (